Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.

Conclusion: The study did not support an overall effect of postdiagnosis low-dose aspirin use on prostate cancer mortality. However, results for extended exposure periods suggest that low-dose aspirin use might be inversely associated with prostate cancer mortality after 5 years from cancer diagnosis.
Primary Funding Source: Danish Cancer Society.
PMID: 30831581 [PubMed - as supplied by publisher]

Source: Annals of Internal Medicine - March 4, 2019 Category: Internal Medicine Authors: Skriver C, Dehlendorff C, Borre M, Brasso K, Larsen SB, Dalton SO, Nørgaard M, Pottegård A, Hallas J, Sørensen HT, Friis S Tags: Ann Intern Med Source Type: research